Dive Brief: Merck has tapped a former executive, Joseph Romanelli, to run the company’s pharmaceutical business in markets outside the U.S. after restructuring its human …

At a quick glance, the Food and Drug Administration’s decision to ask its advisers for help in vetting yet another cancer immunotherapy may seem odd. …

Melanoma is one of the fastest growing malignant cancers in China, increasing at an annual rate of 3-5 percent, which makes it one of the …

Innovent’s IBI101, is the first OX40-targeted molecule to receive IND approval in China Innovent Biologics, a world-class China-based biopharmaceutical company that develops and intends to …

EXPAREL is a non-opioid option for achieving long-lasting pain control after surgery via infiltration into the surgical site or administration as an interscalene brachial plexus …

These patents add to the similar protections won in countries such as India, Korea, Singapore, Canada, Japan and Australia in the past. Suven Life Sciences …